Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
1549–1584
Headlines
2712
Sources here
19
Companies here
17
Current section United States Medical Instruments & Supplies news

Chronological news

Earlier headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Azenta Inc (AZTA) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Azenta Inc (AZTA), focusing on its P/E ratio and overall valuation score. Azenta's current valuation score is 8.18, placing it 160th out of 384 companies in the Biotechnology & Medical Research industry. The company's P/E ratio is …

AZTA main company
Sharemaestro market context Price above Trend Line 52 weeks +5.8% AZTA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Daxor Corporation Launches Outpatient Blood Volume Analysis Program at Kansas Healthcare Facility

Daxor Corporation has launched a new outpatient Blood Volume Analysis (BVA™) program at a major healthcare facility in eastern Kansas, aiming to enhance precision diagnostics and patient outcomes in the Midwest. This initiative utilizes the ezBVA Lab send-out model, allowing healthcare providers to obtain …

DXR main company
Sharemaestro market context Price below Trend Line 52 weeks -5.5% DXR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Daxor launches outpatient blood volume analysis service in Kansas, enhancing precision diagnostics.

Daxor Corporation has launched its ezBVA Lab diagnostic service in eastern Kansas, offering precise outpatient blood volume analysis. This service provides clinicians with 98% accurate measurements of blood, plasma, and red cell volume within 24 hours, without requiring capital equipment from the healthcare facility. …

DXR main company
Sharemaestro market context Price below Trend Line 52 weeks -5.5% DXR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

A Kansas Facility Gets Daxor Blood-Volume Results in 24 Hours

Daxor Corporation has launched an outpatient Blood Volume Analysis (BVA) program in eastern Kansas, providing 98% accurate blood volume measurements within 24 hours. This service uses a CLIA-certified send-out model, eliminating the need for capital equipment at outpatient practices and aiming to improve patient …

DXR main company
Sharemaestro market context Price below Trend Line 52 weeks -5.5% DXR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nyxoah SA (NYXH) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Nyxoah SA (NYXH), detailing its current price momentum score, support and resistance levels, and the status of various technical indicators. It shows the stock is trading between a resistance of $1.72 and support of $1.24, suitable for …

NYXH main company
Sharemaestro market context Price below Trend Line 52 weeks -74.8% · Next-week setup negative 43.6% NYXH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Baxter International Inc (BAX) Institutional Confidence

Baxter International Inc (BAX) has an institutional shareholding score of 10.00, placing it first in the Healthcare Equipment & Supplies industry. Institutional shareholding stands at 108.01%, a slight decrease from the previous quarter. Richard Pzena is the largest institutional shareholder, holding 12.49% of outstanding …

BAX main company
Sharemaestro market context Trend signal active 52 weeks +9.8% BAX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ANGO|AngioDynamics Inc|Price:14.630|Chg%:+0.290

This article provides a comprehensive stock analysis of AngioDynamics Inc (ANGO), highlighting its relatively healthy fundamentals, high growth potential, and fair valuation within the Healthcare Equipment & Supplies industry. It notes high institutional ownership and a recent "Buy" rating from analysts with an expected …

ANGO main company
Sharemaestro market context Trend signal active 52 weeks +67.7% ANGO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ResMed (RMD) Could Be 14% Undervalued On Its Sleep Health Growth Story

ResMed (RMD) has seen a recent rebound in its stock price, with some investors believing it is undervalued by approximately 14% based on its growth narrative in the sleep health market. Strategic investments and increased global awareness of sleep health issues are cited as …

RMD main company
Sharemaestro market context Price above Trend Line 52 weeks -23.0% RMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Premium IOLs Help Propel Strong Q2 as Bausch + Lomb Reports Growth and Raises 2026 Guidance

Bausch + Lomb (NYSE/TSX: BLCO) reported strong second-quarter 2026 financial results, with total revenue increasing by 9 percent to $1.394 billion, driven by double-digit growth in surgical and pharmaceuticals. The company also raised its full-year 2026 revenue guidance. This growth was significantly propelled by …

BLCO main company
Sharemaestro market context Price above Trend Line 52 weeks +14.1% BLCO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

LeMaitre Vascular (LMAT) insider Bridget Ross files to sell 4,322 shares

LeMaitre Vascular insider Bridget A. Ross has filed to sell 4,322 shares of common stock, valued at $449,241.48, through a Form 144. The sale is expected on July 29, 2026, and relates to a stock option exercise. Ross previously sold 5,044 shares for $560,366.40 …

LMAT main company
Sharemaestro market context Price below Trend Line 52 weeks -17.3% · Next-week setup positive 60.5% LMAT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ICUI|ICU Medical Inc|Price:169.747|Chg%:+3.217

This article provides a comprehensive stock analysis of ICU Medical Inc (ICUI), highlighting its strong fundamentals, high growth potential, and "fairly valued" status. It notes high institutional ownership and analyst ratings predominantly as "Buy." The analysis covers its product portfolio and financial performance, including …

ICUI main company
Sharemaestro market context Trend signal active 52 weeks +42.8% ICUI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the proposed sale of Sanara MedTech Inc. (SMTI) to MiMedx Group, Inc. and is encouraging Sanara shareholders to examine their rights and options. The investigation focuses on whether Sanara's board failed to secure the …

SMTI main company
Sharemaestro market context Trend signal active 52 weeks +0.6% · Next-week setup negative 41.2% SMTI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MiMedx Group Q2 Earnings Call Highlights

Key Points Interested in MiMedx Group, Inc? Here are five stocks we like better. MiMedx agreed to acquire Sanara MedTech for $35 per share, adding more than $100 million in surgical revenue and approximately $4 billion in addressable market opportunity. The combined company expects …

SMTI main company
Sharemaestro market context Trend signal active 52 weeks +0.6% · Next-week setup negative 41.2% SMTI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Align Technology Hosts 2026 Invisalign® Ortho Summit, Showcasing a “Beyond Possible” Vision for Connected Digital Orthodontics

Align Technology recently hosted its 2026 Invisalign Ortho Summit, bringing together over 500 orthodontists to explore advancements in digital orthodontic care. The event, themed "Beyond Possible," highlighted new innovations like the Invisalign Specifix System, integrated buttons, and enhanced iTero Lumina intraoral scanner features, aiming …

ALGN main company
Sharemaestro market context Price above Trend Line 52 weeks +21.2% ALGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bausch & Lomb Earnings: Momentum in Implantables and Pharmaceuticals Shows Off Investment Dividends

Bausch & Lomb reported $1.4 billion in revenue, exceeding FactSet consensus by 2% and showing 9% year-over-year growth, though adjusted EPS of $0.17 was 3% below consensus. Despite the mixed earnings, shares remained flat. The report highlights strong first-half performance, indicating that the company's …

BLCO main company
Sharemaestro market context Price above Trend Line 52 weeks +14.1% BLCO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AngioDynamics Number of Employees 2026 | Employee Count & Headcount Data

AngioDynamics, Inc. (ANGO) has 627 employees worldwide as of March 2026, marking a 2.8% decline since 2023 but a 0.1% increase year-over-year. The company is actively hiring, with 58 job postings in 2026, a 39.2% increase from 2025. Its workforce is concentrated in North …

ANGO main company
Sharemaestro market context Trend signal active 52 weeks +67.7% ANGO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MiMedx plans Sanara MedTech (SMTI) acquisition and prepares S-4 filing

MiMedx has announced its intention to acquire Sanara MedTech, aiming to create a larger regenerative medicine platform with a broader product portfolio for wound care and surgical applications. The acquisition is expected to close by year-end, pending customary closing conditions and regulatory approval. MiMedx …

SMTI main company
Sharemaestro market context Trend signal active 52 weeks +0.6% · Next-week setup negative 41.2% SMTI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

BofA Securities Maintains ResMed(RMD.US) With Buy Rating, Maintains Target Price $320

BofA Securities has reiterated its Buy rating for ResMed (RMD.US) and maintained a target price of $320. This indicates a continued positive outlook from the firm regarding ResMed's stock performance.

RMD main company
Sharemaestro market context Price above Trend Line 52 weeks -23.0% RMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Adam Levy signs new employment agreement as NexGel CEO with revised pay and equity

NexGel (NXGL) has executed a new Executive Employment Agreement with its President and CEO, Adam Levy, effective July 23, 2026. This agreement outlines his salary, bonus potential, equity grants, and severance terms. The compensation package includes a base salary of $375,000 and options for …

NXGL main company
Sharemaestro market context New activity signal 52 weeks -75.6% · Next-week setup negative 44.5% NXGL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Transcript : Align Technology, Inc., Q2 2026 Earnings Call, Jul 29, 2026

This article provides the transcript for Align Technology, Inc.'s Second Quarter 2026 Earnings Call held on July 29, 2026. The company, known for Invisalign, reportedly beat quarterly estimates due to strong dental demand. The earnings call includes a presentation by S&P Capital IQ and …

ALGN main company
Sharemaestro market context Price above Trend Line 52 weeks +21.2% ALGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Intuitive Surgical (NASDAQ: ISRG) EVP sells 84 shares in 10b5-1 trades

Intuitive Surgical's EVP & Chief Mfg and Supply Chain, Brosius Mark, sold a total of 84 shares of common stock in three separate open-market transactions between July 27-29, 2026. These sales, conducted at prices ranging from $344.00 to $365.58 per share, were executed under …

ISRG main company
Sharemaestro market context Price below Trend Line 52 weeks -17.1% · Next-week setup negative 41.3% ISRG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bausch + Lomb Upgrades Full-Year Outlook on Strong Second Quarter

Bausch + Lomb has upgraded its full-year outlook following a strong second quarter performance. This positive revision indicates the company's robust financial health and optimistic projections for the remainder of the year.

BLCO main company
Sharemaestro market context Price above Trend Line 52 weeks +14.1% BLCO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Align Technology Releases Q2 2026 Financial Results

Align Technology (ALGN) has announced its second-quarter 2026 financial results, with non-GAAP earnings per share of $2.64, surpassing analyst estimates. The company reported revenue of $1.06 billion, matching forecasts and showing a 4.3% increase year-over-year. The Clear Aligner segment drove performance with an 8.2% …

ALGN main company
Sharemaestro market context Price above Trend Line 52 weeks +21.2% ALGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Align Technology adds directors, boosts buyback after Elliott talks

Align Technology Inc. announced it would add three independent directors to its board and increase its share repurchase commitment to between $400 million and $500 million of common stock. These actions follow discussions with Elliott Investment Management, a major investor in the company. Align …

ALGN main company
Sharemaestro market context Price above Trend Line 52 weeks +21.2% ALGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Align Technology Will Appoint 3 Directors After Elliott Talks

Align Technology (ALGN) announced key strategic initiatives, including the appointment of three new independent directors to its Board following discussions with Elliott Investment Management. The company also launched a comprehensive strategic and operating model review to enhance growth and operational effectiveness. Additionally, Align increased …

ALGN main company
Sharemaestro market context Price above Trend Line 52 weeks +21.2% ALGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bausch & Lomb Corp 2026: Revenue $1.39B, EPS ($0.04) — 10-Q Summary

Bausch & Lomb Corp (BLCO) reported strong second-quarter 2026 results with revenue reaching $1.39 billion, an increase driven by pricing and volume gains across segments. The company significantly reduced its net loss compared to the prior year, with diluted loss per share narrowing to …

BLCO main company
Sharemaestro market context Price above Trend Line 52 weeks +14.1% BLCO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Teleflex receives FDA approval for freeze dried plasma product By Investing.com

Teleflex Incorporated announced FDA approval for its EZPLAZ Freeze Dried Plasma, the first freeze-dried plasma product licensed by the FDA. This product is intended for adults with bleeding conditions requiring plasma coagulation factors when other plasma products are unavailable. EZPLAZ FDP offers logistical advantages …

TFX main company
Sharemaestro market context Trend signal active 52 weeks +6.9% · Next-week setup negative 43.9% TFX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Intuitive Surgical Inc. stock underperforms Wednesday when compared to competitors

Shares of Intuitive Surgical Inc. (ISRG) fell 2.40% on Wednesday, underperforming the broader market. The S&P 500 Index (SPX) dropped 1.52% and the Dow Jones Industrial Average (DJIA) fell 2.19% on the same day. This decline broke a three-day winning streak for Intuitive Surgical …

ISRG main company
Sharemaestro market context Price below Trend Line 52 weeks -17.1% · Next-week setup negative 41.3% ISRG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

BioLife $1.5B buyout to expand Repligen Corporation (NASDAQ: RGEN) platform

Repligen Corporation reported strong Q2 2026 revenue of $204.1 million, an 11.9% increase from Q2 2025, with first-half revenue reaching $398.4 million. The company announced a definitive agreement to acquire BioLife Solutions for approximately $1.5 billion, aiming to expand its cell therapy capabilities. This …

RGEN main company
Sharemaestro market context Trend signal active 52 weeks +33.7% RGEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Azenta Number of Employees 2026 | Employee Count & Headcount Data

Azenta, Inc. (AZTA) had approximately 3,042 total employees worldwide as of March 2026, representing a 6.4% decline from 2023. The company is actively hiring, though job postings decreased by 31.6% in 2026 compared to 2025. The workforce is primarily concentrated in the United States, …

AZTA main company
Sharemaestro market context Price above Trend Line 52 weeks +5.8% AZTA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MIMEDX to acquire Sanara MedTech for $350 million

MiMedx Group Inc. announced its definitive merger agreement to acquire Sanara MedTech Inc. for approximately $350 million. Sanara shareholders will receive $33.00 in cash and 0.4735 shares of MIMEDX common stock per share, representing a 46% premium to Sanara's 30-day volume-weighted average share price. …

SMTI main company
Sharemaestro market context Trend signal active 52 weeks +0.6% · Next-week setup negative 41.2% SMTI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Align Technology (NASDAQ:ALGN) Reports Q2 CY2026 In Line With Expectations But Quarterly Revenue Guidance Slightly Misses Expectations

Align Technology (NASDAQ:ALGN) reported Q2 CY2026 revenue of $1.06 billion, meeting Wall Street expectations with a 4.3% year-on-year increase, and adjusted EPS of $2.64, beating estimates. However, its Q3 CY2026 revenue guidance of $1.01 billion slightly missed analysts' estimates. Despite a strong Q2 performance …

ALGN main company
Sharemaestro market context Price above Trend Line 52 weeks +21.2% ALGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MIMEDX Announces Second Quarter 2026 Operating & Financial Results

Reports Second Quarter Net Sales of $64 Million Reiterates Full Year Financial Outlook on a Standalone Basis Announces Plans to Acquire Sanara MedTech Management to Host Conference Call Today, July 29, 2026, at 4:30 PM ET MARIETTA, Ga., July 29, 2026 (GLOBE NEWSWIRE) -- …

SMTI main company
Sharemaestro market context Trend signal active 52 weeks +0.6% · Next-week setup negative 41.2% SMTI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

BlackRock (NYSE: BLK) discloses 5.6% beneficial stake in KORU Medical Systems (KRMD)

BlackRock, Inc. has filed a Schedule 13G disclosing a 5.6% beneficial ownership stake in KORU Medical Systems (KRMD), amounting to 2,575,761 shares of common stock. The filing indicates BlackRock has sole voting power over 2,537,482 shares and sole dispositive power over all 2,575,761 shares. …

KRMD mentioned
Sharemaestro market context Price below Trend Line 52 weeks -22.4% KRMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Avantor (AVTR) Stock Climbs As Analysts Hike Targets Ahead Q2

Avantor (AVTR) stock has climbed by 13.77% after analysts from firms like BofA, TD Cowen, Citi, and Evercore ISI hiked their price targets ahead of its Q2 2026 earnings release. While most firms maintain a Neutral/Hold rating, the increased targets and positive macro trends …

AVTR main company
Sharemaestro market context Trend signal active 52 weeks +2.9% AVTR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Avantor Inc (AVTR) Q2 2026 Earnings Call Highlights: Strategic Growth and Financial Resilience

This article first appeared on GuruFocus. Revenue: $1.69 billion, declined 0.4% organically, up 0.5% on a reported basis. VWR Segment Revenue: $1.24 billion, up 1.7% organically. BMP Segment Revenue: $452 million, down 5.6% organically. Adjusted EBITDA: $254 million, margin of 15%. Adjusted Earnings Per …

AVTR main company
Sharemaestro market context Trend signal active 52 weeks +2.9% AVTR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context